Viewing Study NCT00178243



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00178243
Status: COMPLETED
Last Update Posted: 2006-09-08
First Post: 2005-09-12

Brief Title: Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation
Sponsor: University of Rochester
Organization: University of Rochester

Study Overview

Official Title: A Phase III Trial Of the Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation Delivered by 3D Conformal Radiation Therapy and Radiosurgery
Status: COMPLETED
Status Verified Date: 2006-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A study is being conducted by the University of Rochester Cancer Center URCC in which patients with liver cancer will be treated with high dose conformal radiation therapy This type of radiation uses new techniques which aim the radiation to the sites of disease allowing the tumor to receive a high dose and the surrounding normal liver tissue to receive a low enough dose that the normal tissue should remain free from injury

The purpose of the study is to determine if the conformal radiation therapy is safe tolerable and effective in treating liver cancer and to determine the side effects caused by this treatment A second objective is to determine if the levels of a special type of protein called cytokines found in the blood are related to this treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None